Label Expansion for Astellas Drug - Analyst Blog Astellas Pharma Inc. ( ALPMY ) recently announced the approval of Prograf in Japan for an additional indication. Prograf is now approved for interstitial pneumonia associated with
June 17, 2013 - Nasdaq